The parallels between the consequences of SETD2 and LKB1 inactivation are all the more provocative given an apparent functional-genetic epistatic relationship in KRAS-driven mouse models and their mutually exclusive pattern of mutation in human of lung adenocarcinoma patients2,15. The gene discussed is KRAS; the disease is lung adenocarcinoma.